SCHEMBL899069

SCHEMBL899069

CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 20/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7529028 1.00 FDPS (0.41) FDPS
SCHEMBL617158 1.00 FDPS (0.41) FDPS
SCHEMBL1773792 0.97 FDPS (0.41) FDPS
Phosphoric Acid SCHEMBL5449030 0.95 FDPS (0.43) FDPS
SCHEMBL669819 0.94 FDPS (0.43) FDPS
SCHEMBL6264031 0.94 FDPS (0.43) FDPS
SCHEMBL4486157 0.94 FDPS (0.43) FDPS
SCHEMBL4489691 0.94 FDPS (0.43) FDPS
SCHEMBL28904337 0.94 FDPS (0.43) FDPS
SCHEMBL28390378 0.94 FDPS (0.43) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3431528-B1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER BOEING CO (US) 2020-09-02 EP claimed
EP-3114105-B1 METHOD FOR PRODUCING ALDEHYDES FROM ALKANES AND SYNTHESIS GAS EVONIK DEGUSSA GMBH (DE) 2018-05-09 EP claimed
EP-3038752-B1 CATALYST AND METHOD FOR THE HYDROFORMYLATION OF UNSATURATED COMPOUNDS BY MEANS OF SILP CATALYSIS EVONIK DEGUSSA GMBH (DE) 2017-07-19 EP claimed
US-8748671-B2 Ether production method involving alcohol separation by an ionic liquid IFP Energies Nouvelles (FR) 2014-06-10 US claimed
EP-2621628-A1 USE OF SUPPORTED IONIC LIQUID PHASE (SILP) CATALYST SYSTEMS IN THE HYDROFORMYLATION OF OLEFIN-CONTAINING MIXTURES TO GIVE ALDEHYDE MIXTURES WITH A HIGH PROPORTION OF 2-UNBRANCHED ALDEHYDES Evonik Oxeno GmbH (DE) 2013-08-07 EP claimed
WO-2012041846-A1 USE OF SUPPORTED IONIC LIQUID PHASE (SILP) CATALYST SYSTEMS IN THE HYDROFORMYLATION OF OLEFIN-CONTAINING MIXTURES TO GIVE ALDEHYDE MIXTURES WITH A HIGH PROPORTION OF 2-UNBRANCHED ALDEHYDES EVONIK OXENO GMBH (DE) 2012-04-05 WO claimed
US-20110021847-A1 ETHER PRODUCTION METHOD INVOLVING ALCOHOL SEPARATION BY AN IONIC LIQUID IFP (FR) 2011-01-27 US claimed
US-7459134-B2 Method of decarbonating a combustion fume with extraction of the solvent contained in the purified fume INSTITUT FRANCAIS DU PETROLE 2008-12-02 US claimed
US-20080038123-A1 Processing and/or operating machine comprising an ionic liquid as the operating liquid MERCK PATENT GMBH (DE) 2008-02-14 US claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO claimed
US-20060188423-A1 Method of decarbonating a combustion fume with extraction of the solvent contained in the purified fume EVONIK DEGUSSA GMBH (DE) 2006-08-24 US claimed
US-20260041781-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS AND IMMUNOCONJUGATES THEREOF ADCENTRX THERAPEUTICS INC (US) 2026-02-12 US disclosed
EP-3744707-B1 PROCESS FOR HYDROFORMYLATION OF SHORT-CHAIN OLEFINS IN THE RECYCLE STREAM OF A LIQUID PHASE HYDROFORMYLATION EVONIK OXENO GMBH & CO KG (DE) 2024-01-10 EP disclosed
US-20230361308-A1 DISPERSIONS OF CARBON NANOTUBES FOR USE IN COMPOSITIONS FOR MANUFACTURING BATTERY ELECTRODES PPG INDUSTRIES OHIO, INC. (US) 2023-11-09 US disclosed
EP-3736258-B1 PROCESS FOR HYDROFORMYLATION OF SHORT-CHAIN OLEFINS IN ALKANE-RICH EXHAUST GAS STREAMS EVONIK OPERATIONS GMBH (DE) 2023-11-01 EP disclosed
EP-1569621-A1 MICROPARTICLES PREPARED USING AN IONIC LIQUID Novartis AG (CH) 2005-09-07 EP disclosed
EP-1182196-B1 Halogen-free preparation of ionic fluids SOLVENT INNOVATION GMBH (DE) 2004-06-30 EP disclosed
WO-2004052340-A1 MICROPARTICLES PREPARED USING AN IONIC LIQUID NOVARTIS AG (CH) 2004-06-24 WO disclosed
EP-1182196-A1 Halogenide-free preparation of ionic fluids Solvent Innovation GmbH (DE) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021847-A1 ETHER PRODUCTION METHOD INVOLVING ALCOHOL SEPARATION BY AN IONIC LIQUID ADH1C, ADH1A, ADH5 FDPS 3070/4885
US-20260041781-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS AND IMMUNOCONJUGATES THEREOF NR3C1, NR3C2, MC2R FDPS 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.